Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test. (29th December 2020)
- Record Type:
- Journal Article
- Title:
- Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test. (29th December 2020)
- Main Title:
- Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test
- Authors:
- Borup, Christian
Wildt, Signe
Rumessen, Jüri
Graff, Jesper
Bouchelouche, Pierre Nordine
Andersen, Trine Borup
Vinter-Jensen, Lars
Zaremba, Anna
German Jørgensen, Søren Peter
Gregersen, Tine
Nøjgaard, Camilla
Timm, Hans Bording
Rainteau, Dominique
Gauliard, Emilie
Munck, Lars Kristian - Abstract:
- Abstract : INTRODUCTION: The diagnosis of bile acid diarrhea is often missed because the availability of the 75 seleno-taurohomocholic acid (SeHCAT) test is limited. We aimed to compare the biomarkers 7α-hydroxy-4-cholesten-3-one (C4) and fibroblast growth factor 19 (FGF19) with the SeHCAT test. METHODS: Patients with chronic diarrhea without intestinal resection referred for SeHCAT were prospectively recruited for this diagnostic accuracy study. Blood was sampled at fasting and after a stimulation meal with chenodeoxycholic acid. SeHCAT retention ≤10% defined bile acid diarrhea and >10% defined miscellaneous diarrhea. Receiver operating characteristics (ROC) were analyzed with SeHCAT as the gold standard. www.clinicaltrials.gov (NCT03059537). RESULTS: Patients with bile acid diarrhea (n = 26) had mean C4 of 30 ng/mL (95% confidence interval: 19–46) vs 8 (7–11; P < 0.001) in the miscellaneous diarrhea group (n = 45). Area under the ROC curve (ROCAUC ) for C4 was 0.83 (0.72–0.93). C4 < 15 ng/mL had 85% (74%–96%) negative predictive value; C4 > 48 ng/mL had 82% (59%–100%) positive predictive value. Twenty patients had C4 values 15–48 ng/mL, of whom 11/20 had SeHCAT ≤10%. Median fasting FGF19 was 72 pg/mL (interquartile range: 53–146) vs 119 (84–240) ( P = 0.004); ROCAUC was 0.71 (0.58–0.83). Stimulated FGF19 responses did not differ ( P = 0.54). DISCUSSION: We identified C4 thresholds with clinically useful predictive values for the diagnosis of and screening for bile acidAbstract : INTRODUCTION: The diagnosis of bile acid diarrhea is often missed because the availability of the 75 seleno-taurohomocholic acid (SeHCAT) test is limited. We aimed to compare the biomarkers 7α-hydroxy-4-cholesten-3-one (C4) and fibroblast growth factor 19 (FGF19) with the SeHCAT test. METHODS: Patients with chronic diarrhea without intestinal resection referred for SeHCAT were prospectively recruited for this diagnostic accuracy study. Blood was sampled at fasting and after a stimulation meal with chenodeoxycholic acid. SeHCAT retention ≤10% defined bile acid diarrhea and >10% defined miscellaneous diarrhea. Receiver operating characteristics (ROC) were analyzed with SeHCAT as the gold standard. www.clinicaltrials.gov (NCT03059537). RESULTS: Patients with bile acid diarrhea (n = 26) had mean C4 of 30 ng/mL (95% confidence interval: 19–46) vs 8 (7–11; P < 0.001) in the miscellaneous diarrhea group (n = 45). Area under the ROC curve (ROCAUC ) for C4 was 0.83 (0.72–0.93). C4 < 15 ng/mL had 85% (74%–96%) negative predictive value; C4 > 48 ng/mL had 82% (59%–100%) positive predictive value. Twenty patients had C4 values 15–48 ng/mL, of whom 11/20 had SeHCAT ≤10%. Median fasting FGF19 was 72 pg/mL (interquartile range: 53–146) vs 119 (84–240) ( P = 0.004); ROCAUC was 0.71 (0.58–0.83). Stimulated FGF19 responses did not differ ( P = 0.54). DISCUSSION: We identified C4 thresholds with clinically useful predictive values for the diagnosis of and screening for bile acid diarrhea in patients with chronic watery diarrhea. Further validation of the cutoff values with the placebo-controlled effect of sequestrant therapy is warranted (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/AJG/B603 ). … (more)
- Is Part Of:
- American journal of gastroenterology. Volume 115:Number 12(2020)
- Journal:
- American journal of gastroenterology
- Issue:
- Volume 115:Number 12(2020)
- Issue Display:
- Volume 115, Issue 12 (2020)
- Year:
- 2020
- Volume:
- 115
- Issue:
- 12
- Issue Sort Value:
- 2020-0115-0012-0000
- Page Start:
- 2086
- Page End:
- 2094
- Publication Date:
- 2020-12-29
- Subjects:
- Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Gastrointestinal Diseases -- Periodicals
Electronic journals
Periodicals
616.33 - Journal URLs:
- http://www.mdconsult.com/public/search?search_type=journal&j_sort=pub_date&j_date_range=1995-current&j_issn=0002-9270 ↗
http://www.amjgastro.com/ ↗
http://www.nature.com/ajg/archive/index.html ↗
http://www.sciencedirect.com/science/journal/00029270 ↗
http://www.nature.com/ ↗
http://www3.interscience.wiley.com/journal/117955841/home ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0002-9270;screen=info;ECOIP ↗ - DOI:
- 10.14309/ajg.0000000000000772 ↗
- Languages:
- English
- ISSNs:
- 0002-9270
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.650000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24127.xml